| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/04/1997 | US5599833 Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes |
| 02/04/1997 | CA1338888C Matrix with immunomodulating activity |
| 01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997002820A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 01/30/1997 | WO1996041815A3 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
| 01/30/1997 | WO1996041607A3 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226490A1 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/29/1997 | EP0755684A1 Vaccine conjugate |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755439A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
| 01/29/1997 | EP0755407A1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 01/29/1997 | EP0755393A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 01/29/1997 | EP0755381A1 Substituted pyridine leukotriene b 4 antagonists |
| 01/29/1997 | EP0755380A1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same |
| 01/29/1997 | EP0755252A1 Method of treating allergic rhinitis |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0594702B1 Substituted indoles as anti-aids pharmaceuticals |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141632A 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141196A Application of quinoxalines in combination with protease inhibitors as medicaments |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/28/1997 | US5597901 Homogeneous human interleukin 2 |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597847 Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino) phenylacetic acid and process for their preparation |
| 01/28/1997 | US5597833 Leukotriene synthesis inhibitors for antiinflammatory agents, respiratory system disorders, antiallergens or antiischemic agents |
| 01/28/1997 | US5597819 Antiinflammatory agents |
| 01/28/1997 | US5597715 7,42-Bis(O-demethyl)rapamycin |
| 01/28/1997 | US5597710 Genetic engineering |
| 01/28/1997 | US5597607 Process for preparing fractionated soybean proteins and foods using the same |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/28/1997 | CA2012666C Diazepine antiallergy agents |
| 01/28/1997 | CA1338878C 14-beta-gal mammalian lectins |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002285A1 Macrolides |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002249A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002042A1 Biologically active composition comprising cyclosporine |
| 01/23/1997 | WO1997002023A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
| 01/23/1997 | CA2226219A1 Biologically active composition comprising cyclosporine |
| 01/23/1997 | CA2225668A1 Use of stat 6 sh2 domain specific compounds to treat allergic reactions |
| 01/23/1997 | CA2225616A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | CA2224715A1 Macrolides |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754459A1 Composition containing glycans corresponding to transferrin glycans as an active principle for the induction of immune tolerance against antigens |
| 01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
| 01/22/1997 | EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| 01/22/1997 | EP0754057A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING $g(a)-GALACTOSYL EPITOPES |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754040A1 Rapamycin derivatives |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | EP0687177B1 Use of lamotrigine for treating aids-related neural disorders |
| 01/22/1997 | EP0601002B1 Bicyclic sulphones, process for producing the same and medicaments containing the same |
| 01/22/1997 | EP0559695B1 New pyridine derivatives, methods of preparing them and their use as drugs |
| 01/22/1997 | EP0549581B1 Framework mutated antibodies and their preparation |
| 01/22/1997 | EP0531401B1 Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141040A 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 01/22/1997 | CN1141039A 4-amino derivatives of 5-substituted mycophenolic acid |
| 01/22/1997 | CN1141038A 5-substituted derivatives of mycophenolic acid |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/22/1997 | CN1140710A N,N-diethyl-8,8-dipropyl-2-azaspiro(4,5) decane-2-propanamine dimaleate |
| 01/21/1997 | US5596106 Cannabinoid receptor antagonists |
| 01/21/1997 | US5596013 Inhibitors of phosphodiesterase type iv and production of tumor necrosis factor |
| 01/21/1997 | US5596003 Piperidinyl thiacyclic derivatives |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595988 Antiallergens |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001350A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | CA2226017A1 Cd4-derived peptides that inhibit immune responses |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/15/1997 | EP0753582A1 Immunopotentiator and method of manufacturing the same |
| 01/15/1997 | EP0753512A1 N,N,-diethyl-8,8dipropyl-2-azaspiro(4,5)decane-2-propanamine dimaleate salt |
| 01/15/1997 | EP0753305A1 Anti-HIV composition and method for treating HIV infection with an anti-HIV agent containing crude drug |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |